STOCK TITAN

Decibel Announces Stock Option Grants

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags

Decibel Cannabis Company (OTCQB: DBCCF) granted an aggregate of 11,537,223 stock options effective after market close on February 10, 2026. Each Option is exercisable for one common share at $0.10 per share, the TSXV closing price on February 10, 2026.

The grant is a normal-course, long-term compensation and retention measure. Options vest in three equal annual installments on Jan 1, 2027, 2028 and 2029 and expire on Feb 10, 2031. The company operates cultivation and processing facilities across Canada and sells branded products domestically and beginning international expansion.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

CALGARY, AB, Feb. 11, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, announces that it has granted, effective after market close on February 10, 2026, an aggregate of 11,537,223 stock options (each, an "Option") to certain officers and employees of the Company in accordance with the Company's stock option plan.

Each Option is exercisable for one common share in the capital of the Company (a "Share") at a price of $0.10 per Share, being the closing price of the Shares on the TSX Venture Exchange on February 10, 2026. This is a normal-course grant that comprises part of the long-term compensation and employee retention incentives program provided by the Company. The Options will vest in three equal annual installments on January 1 in each of 2027, 2028 and 2029 and will expire on February 10, 2031.

About Decibel

Decibel is a consumer-focused cannabis company focused on delivering products that delight customers through a commitment to robust innovation and product quality. Leading brands General Admission, Qwest and Standard Issue are among its portfolio sold both across Canada and beginning to extend towards new countries to create a global footprint. Decibel operates a processing and manufacturing facility in Calgary, Alberta, two cultivation facilities in Creston, British Columbia and Battleford, Saskatchewan, and an EUGMP licensed cultivation and processing facility in Chatham, Ontario.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation, including statements that relate to Decibel's business plans generally, and specifically the creation of a global footprint and ability to delight customers through a commitment to robust innovation and product quality. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, the Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Many of these risks and uncertainties and additional risk factors generally applicable to the Company are described in the Company's management's discussion and analysis for the three and nine months ended September 30, 2025 and 2024, which are available under the Company's profile at www.sedarplus.ca.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/decibel-announces-stock-option-grants-302684618.html

SOURCE Decibel Cannabis Company Inc.

FAQ

What did Decibel (DBCCF) announce on February 11, 2026 about stock options?

Decibel announced a grant of 11,537,223 stock options effective after market close on February 10, 2026. According to Decibel, the grant is part of its long-term compensation and employee retention program and is described as a normal-course award.

What are the exercise price and expiry details for the DBCCF stock options granted?

Each option is exercisable for one common share at an exercise price of $0.10 per share. According to Decibel, the options will expire on February 10, 2031 and follow the company's option plan terms.

How do the Decibel (DBCCF) options vest and when are the vesting dates?

The options vest in three equal annual installments on January 1, 2027, 2028 and 2029. According to Decibel, vesting is structured as part of its long-term compensation and employee retention incentives program.

Why did Decibel (DBCCF) grant 11.5 million stock options to employees and officers?

The grant is described as a normal-course element of long-term compensation and employee retention. According to Decibel, the options aim to align employee incentives with company performance and support retention under its stock option plan.

Does the Decibel (DBCCF) announcement state how the $0.10 exercise price was determined?

The exercise price of $0.10 equals the closing price of Decibel shares on the TSX Venture Exchange on February 10, 2026. According to Decibel, the price reflects the market close used for the grant effective after market close that day.
Decibel Cannabis

OTC:DBCCF

DBCCF Rankings

DBCCF Latest News

DBCCF Stock Data

54.11M
428.80M
23.44%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Calgary